RU2015127482A - Детское питание для улучшения состава жирных кислот в мембранах клеток мозга - Google Patents

Детское питание для улучшения состава жирных кислот в мембранах клеток мозга Download PDF

Info

Publication number
RU2015127482A
RU2015127482A RU2015127482A RU2015127482A RU2015127482A RU 2015127482 A RU2015127482 A RU 2015127482A RU 2015127482 A RU2015127482 A RU 2015127482A RU 2015127482 A RU2015127482 A RU 2015127482A RU 2015127482 A RU2015127482 A RU 2015127482A
Authority
RU
Russia
Prior art keywords
mass
lipids
composition
fatty acids
total
Prior art date
Application number
RU2015127482A
Other languages
English (en)
Other versions
RU2692920C2 (ru
RU2015127482A3 (ru
Inventor
ДЕР БЕК Элине Марлен ВАН
Мариеке АБРАХАМСЕ-БЕРКЕВЕЛД
Аннемик Лидевей СХИППЕР
Гелске СПЕЛМАНС
Original Assignee
Н.В. Нютрисиа
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43487597&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2015127482(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Н.В. Нютрисиа filed Critical Н.В. Нютрисиа
Publication of RU2015127482A publication Critical patent/RU2015127482A/ru
Publication of RU2015127482A3 publication Critical patent/RU2015127482A3/ru
Application granted granted Critical
Publication of RU2692920C2 publication Critical patent/RU2692920C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/01Other fatty acid esters, e.g. phosphatides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/01Other fatty acid esters, e.g. phosphatides
    • A23D7/011Compositions other than spreads
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013Other fatty acid esters, e.g. phosphatides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/02Other edible oils or fats, e.g. shortenings, cooking oils characterised by the production or working-up
    • A23D9/04Working-up
    • A23D9/05Forming free-flowing pieces
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00Phosphatide compositions for foodstuffs, e.g. lecithin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/30Encapsulation of particles, e.g. foodstuff additives
    • A23P10/35Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pediatric Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Claims (18)

1. Способ улучшения i) когнитивного развития, ii) поведенческой функций, iii) остроты зрения, iv) мелкой моторики у субъекта-человека путем введения питательной композиции, содержащей липиды, причем указанная питательная композиция содержит
а) 10-50% масс. растительных липидов на сухую массу композиции, и
b1) 0,5-20% масс. фосфолипидов от общей массы липидов, и/или
b2) 0,6-25% масс. полярных липидов от общей массы липидов,
где полярные липиды являются суммой фосфолипидов, гликосфинголипидов и холестерина,
и указанная композиция содержит липидные глобулы с ядром, включающим указанные растительные липиды, и покрытием, включающим указанные фосфолипиды или полярные липиды.
2. Способ по п. 1, где указанные липидные глобулы имеют:
1. взвешенный на объем модальный диаметр более 1,0 мкм, предпочтительно от 1,0 до 10 мкм, и/или
2. диаметр от 2 до 12 мкм в количестве по меньшей мере 45, более предпочтительно по меньшей мере 55 объемных % от общего объема липидов.
3. Способ по п. 1, где композиция содержит n3 LC-PUFA в количестве по меньшей мере 0,2% масс. от общего содержания жирных кислот, и оно не превышает 15% масс. от общего содержания жирных кислот.
4. Способ по п. 1, где композиция содержит DHA в количестве от 0,1 до 0,6% масс. от общего содержания жирных кислот.
5. Способ по п. 1, где композиция содержит n6 LC-PUFA в количестве по меньшей мере 0,02% масс. от общего содержания жирных кислот, и оно не превышает 5% масс. общего содержания жирных кислот.
6. Способ по п. 1, где композиция содержит ARA в количестве от 0,1 до 0,6% масс. от общего содержания жирных кислот.
7. Способ по п. 1, где питательная композиция содержит линолевую кислоту (LA) и альфа-линоленовую кислоту (ALA) в массовом соотношении LA : ALA от 4 до 7.
8. Способ по п. 1, где фосфолипиды получают из молока.
9. Способ по п. 1, где композиция предназначена для кормления субъекта-человека в возрасте от 0 до 36 месяцев.
10. Способ по п. 1, где композиция представляет собой порошок, подходящий для получения жидкой композиции после восстановления водным раствором, предпочтительно водой.
11. Способ по п. 1, где улучшенное когнитивное развитие представляет собой улучшенное развитие обучения и памяти.
RU2015127482A 2010-03-17 2011-03-17 Детское питание для улучшения состава жирных кислот в мембранах клеток мозга RU2692920C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/NL2010/050142 WO2011115476A1 (en) 2010-03-17 2010-03-17 Infant nutrition for improving fatty acid composition of brain membranes later in life
NLPCT/NL2010/050142 2010-03-17

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2012144016/13A Division RU2559113C2 (ru) 2010-03-17 2011-03-17 Детское питание для улучшения состава жирных кислот в мембранах клеток мозга

Publications (3)

Publication Number Publication Date
RU2015127482A true RU2015127482A (ru) 2018-12-24
RU2015127482A3 RU2015127482A3 (ru) 2018-12-24
RU2692920C2 RU2692920C2 (ru) 2019-06-28

Family

ID=43487597

Family Applications (4)

Application Number Title Priority Date Filing Date
RU2012144016/13A RU2559113C2 (ru) 2010-03-17 2011-03-17 Детское питание для улучшения состава жирных кислот в мембранах клеток мозга
RU2012144021/13A RU2560861C2 (ru) 2010-03-17 2011-03-17 Детское питание для улучшения состава жирных кислот в мембранах клеток мозга
RU2015127482A RU2692920C2 (ru) 2010-03-17 2011-03-17 Детское питание для улучшения состава жирных кислот в мембранах клеток мозга
RU2015130598A RU2692627C2 (ru) 2010-03-17 2011-03-17 Детское питание для улучшения состава жирных кислот в мембранах клеток мозга

Family Applications Before (2)

Application Number Title Priority Date Filing Date
RU2012144016/13A RU2559113C2 (ru) 2010-03-17 2011-03-17 Детское питание для улучшения состава жирных кислот в мембранах клеток мозга
RU2012144021/13A RU2560861C2 (ru) 2010-03-17 2011-03-17 Детское питание для улучшения состава жирных кислот в мембранах клеток мозга

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU2015130598A RU2692627C2 (ru) 2010-03-17 2011-03-17 Детское питание для улучшения состава жирных кислот в мембранах клеток мозга

Country Status (9)

Country Link
US (4) US20130096087A1 (ru)
EP (4) EP3332649B1 (ru)
CN (3) CN102892300B (ru)
BR (2) BR112012023264A8 (ru)
ES (2) ES2656154T3 (ru)
MY (1) MY166016A (ru)
PL (2) PL2547216T3 (ru)
RU (4) RU2559113C2 (ru)
WO (3) WO2011115476A1 (ru)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3682874A1 (en) * 2008-09-02 2020-07-22 N.V. Nutricia Nutritional compositions with coated lipid globules
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
WO2013059669A1 (en) * 2011-10-21 2013-04-25 Omthera Pharmaceuticals, Inc. Methods and compositions for treating or preventing attention deficit hyperactivity disorder
SE536599C3 (sv) 2012-04-10 2017-01-10 Hero Ag Näringssammansättning med lågt kalori- och lågt proteininnehåll
WO2014058301A1 (en) * 2012-10-12 2014-04-17 N.V. Nutricia Infant nutrition with lipid globules to increase energy expenditure and metabolic flexibility later in life
US10455854B2 (en) 2013-03-11 2019-10-29 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US9980506B2 (en) 2013-03-11 2018-05-29 Mead Johnson Nutrition Co. Nutritional compositions containing structured fat globules and uses thereof
US9661874B2 (en) 2013-03-11 2017-05-30 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US10709770B2 (en) 2013-07-31 2020-07-14 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US9609888B2 (en) 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
WO2015065193A1 (en) 2013-11-01 2015-05-07 N.V. Nutricia Lipid composition for improving body composition during catch-up growth
CN105792675A (zh) * 2013-12-12 2016-07-20 雀巢产品技术援助有限公司 用于促进男性和女性婴儿及儿童认知功能的健康建立的包含多不饱和脂肪酸类(pufa)的合成乳组合物
WO2016024864A1 (en) 2014-08-15 2016-02-18 N.V. Nutricia Lipid composition for improving behaviour
FR3026918B1 (fr) * 2014-10-13 2018-02-23 Even Sante Industrie Procede d'obtention d'un lait infantile pret a l'emploi et de longue conservation
CN106998774A (zh) * 2014-11-26 2017-08-01 雅培制药有限公司 包含人乳低聚糖、多不饱和脂肪酸、核苷酸以及叶黄素的婴儿配方
PL3280277T3 (pl) * 2015-04-10 2021-12-13 N.V. Nutricia Zastosowanie kompozycji odżywczej z dużymi kulkami lipidowymi zawierającymi tłuszcz roślinny pokryty fosfolipidami mleka do trawienia lipidów
US10617701B2 (en) 2015-07-10 2020-04-14 Mead Johnson Nutrition Company Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
CA2995834A1 (en) 2015-08-17 2017-02-23 St Ip Holding Ag Honokiol and magnolol formulations with increased stability and improved uptake, and methods of use thereof
DK3361885T3 (da) 2015-10-15 2019-07-29 Nutricia Nv Modermælkserstatning med særlig lipidarkitektur til fremme af sund vækst
WO2017117121A1 (en) * 2015-12-28 2017-07-06 Abbott Laboratories Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof
EP3445353A1 (en) * 2016-04-18 2019-02-27 N.V. Nutricia Linoleic acid and alpha-li nolenic acid for use for reducing early-life stress induced cognitive decline/reduction in neurogenesis
WO2017183956A1 (en) * 2016-04-18 2017-10-26 N.V. Nutricia Linoleic acid and alpha-linolenic acid for use for reducing early-life stress induced cognitive decline
CN109996441B (zh) 2016-11-04 2022-02-08 瑞泽恩制药公司 具有经工程化的免疫球蛋白λ轻链基因座的非人类动物
WO2018104512A1 (en) 2016-12-09 2018-06-14 N.V. Nutricia Nutritional composition for improving cell membranes
EP3599896A1 (en) * 2017-03-29 2020-02-05 N.V. Nutricia Infant formula for improved eating behaviour
CN112087956A (zh) * 2018-04-03 2020-12-15 N·V·努特里奇亚 用于预防干性皮肤的营养组合物
US20230046623A1 (en) * 2020-01-31 2023-02-16 N.V. Nutricia Nutritional composition for use in gut maturation
CN115315198A (zh) * 2020-04-01 2022-11-08 三得利控股株式会社 友好性及/或共情力改善用组合物
WO2023208925A1 (en) 2022-04-25 2023-11-02 N.V. Nutricia Nutritional composition for use in preventing programmed obesity in female infants
WO2023232882A1 (en) 2022-05-31 2023-12-07 N.V. Nutricia Infant formula for improving cognitive development

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1084006A1 (ru) 1981-11-09 1984-04-07 Казахский Филиал Института Питания Амн Ссср Способ приготовлени пищевой эмульсии
NL8800629A (nl) 1988-03-15 1989-10-02 Ver Coop Melkind Gesproeidroogd melkpoederprodukt en werkwijze voor de bereiding daarvan.
ES2033193B1 (es) 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
IL119982A (en) 1997-01-09 2000-07-26 Shapira Niva Bottle for infant feeding
EP0986377A1 (en) 1997-03-27 2000-03-22 Bristol-Myers Squibb Company Use of docosahexanoic acid and arachidonic acid enhancing the growth of preterm infants
JP2001158736A (ja) 1999-11-30 2001-06-12 Snow Brand Milk Prod Co Ltd 骨関節疾患の予防及び改善剤
US6495599B2 (en) * 2000-04-13 2002-12-17 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses therof
US7090862B2 (en) 2001-03-30 2006-08-15 Abbott Laboratories Method of improving the antioxidant status of an infant
US6620427B2 (en) 2001-04-24 2003-09-16 Abbott Laboratories Method for improving bone mineralization
US20050019372A1 (en) 2001-07-10 2005-01-27 Barbara E Corkey Modified-fat nutritional products useful preventing or treating obesity
US6902739B2 (en) 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility
MY137957A (en) 2003-07-16 2009-04-30 Idemitsu Kosan Co Apparatus of applying ultrasonic vibration to resin material, method of kneading, compounding and blending resin material by use of the ultrasonic vibration applying apparatus, and resin composition
JP2007501241A (ja) 2003-08-06 2007-01-25 ローディア インコーポレイティド 骨成長を促進する方法
IL158555A0 (en) 2003-10-22 2004-05-12 Enzymotec Ltd Human breast milk lipid mimetic as dietary supplement
IL158554A0 (en) 2003-10-22 2004-05-12 Enzymotec Ltd Mimetic lipids as dietary supplements
EP1684593A4 (en) 2003-11-20 2010-02-10 Alteragon Pty Ltd METHOD FOR REDUCING FAT DEPOSITS AND BODY WEIGHT IN MAMMALS AND BIRDS
US9040075B2 (en) 2003-12-19 2015-05-26 Abbott Laboratories Method of increasing lean body mass and reducing body fat mass in infants
US8252769B2 (en) * 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
US20080108548A1 (en) 2004-11-12 2008-05-08 N.V. Nutricia Food Composition For Rapidly Attenuating Inflammatory Responses
BRPI0609024A2 (pt) 2005-03-08 2010-01-12 Nestec Sa produto sólido extrusado para uso em produtos alimentìcios
US20060210697A1 (en) 2005-03-18 2006-09-21 Mower Thomas E Infant formula composition
EP1898722B1 (en) 2005-04-28 2013-04-10 Enzymotec Ltd. Polar lipid mixtures, their preparation and uses
TWI282268B (en) 2005-09-15 2007-06-11 Univ Chung Shan Medical Medical image system and method for measuring vertebral axial rotation
US7311676B2 (en) 2005-09-23 2007-12-25 Park Sangdo Portable non-invasive device for measuring the hardness of muscle or muscle compartment
DE602006011195D1 (de) 2005-10-05 2010-01-28 Nestec Sa Verwendung einer nährstoffformulierung zur förderung des aufholwachstums
WO2008054192A1 (en) 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
ATE509624T1 (de) 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
PL1962823T3 (pl) 2005-12-23 2015-08-31 Nutricia Nv Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka i mangan i/lub molibden do poprawy składu błony komórkowej
KR100598607B1 (ko) 2006-02-24 2006-07-07 주식회사 일신웰스 유지 조성물 및 이의 제조방법
US20080003330A1 (en) 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
WO2008003330A1 (en) * 2006-07-07 2008-01-10 Danmarks Tekniske Universitet (Technical University Of Denmark) Variable trailing edge section geometry for wind turbine blade
EP1932437A1 (en) 2006-12-15 2008-06-18 Nestec S.A. Infant formula
CN101636167B (zh) 2006-12-28 2012-10-03 株式会社明治 含有乳来源的磷脂的婴幼儿脑发育促进剂以及含有该促进剂的食品组合物
LT2211629T (lt) 2007-10-19 2020-08-25 Fonterra Co-Operative Group Limited Priežiūros arba augimo arba kognityvinės raidos skatinimo būdai
KR20150126977A (ko) 2007-11-01 2015-11-13 엔지모테크 리미티드 유아 영양을 위한 지질 혼합물
CN101939010A (zh) 2007-11-19 2011-01-05 雪印乳业株式会社 感觉改善剂
FR2930406B1 (fr) 2008-04-29 2011-04-15 Groupe Lactalis Aliment infantile a base de matiere grasse d'origine laitiere
US20110097438A1 (en) 2008-06-16 2011-04-28 N.V. Nutricia Composition with fat gradient
EP3682874A1 (en) * 2008-09-02 2020-07-22 N.V. Nutricia Nutritional compositions with coated lipid globules
WO2010068086A1 (en) 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
WO2010070613A2 (en) 2008-12-18 2010-06-24 University College London Baby feeding formula and system
WO2010134800A1 (en) 2009-05-19 2010-11-25 N.V. Nutricia Human milk fortifier with high protein and long chain poly unsaturated fatty acids for improving body adipose tissue distribution
WO2011071367A1 (en) 2009-12-11 2011-06-16 N.V. Nutricia Metabolic imprinting effects of structured lipids
WO2011108918A1 (en) 2010-03-04 2011-09-09 N.V. Nutricia Modulation of post-prandial fat absorption
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
WO2012173467A1 (en) 2011-06-16 2012-12-20 N.V. Nutricia Metabolic imprinting effects of specifically designed lipid component
WO2013036104A1 (en) 2011-09-08 2013-03-14 N.V. Nutricia Infant nutrition for regulating food intake later in life
WO2013036103A1 (en) 2011-09-08 2013-03-14 N.V. Nutricia Use of infant formula with large lipid globules
WO2013036102A1 (en) 2011-09-08 2013-03-14 N.V. Nutricia Use of infant formula with cholesterol
EP2583562A1 (en) 2011-10-21 2013-04-24 Nestec S.A. Use of whey protein micelles for infants at risk of obesity or diabetes
SE536599C3 (sv) 2012-04-10 2017-01-10 Hero Ag Näringssammansättning med lågt kalori- och lågt proteininnehåll
WO2013191533A1 (en) 2012-06-18 2013-12-27 N.V. Nutricia Metabolic imprinting effects of nutrition with large lipid globules comprising milk fat and vegetable fat
WO2015065193A1 (en) 2013-11-01 2015-05-07 N.V. Nutricia Lipid composition for improving body composition during catch-up growth
EP3082463B1 (en) 2013-11-29 2019-05-01 Nestec S.A. Use of nutritional compositions having a low protein amount
CN105899089A (zh) 2013-12-19 2016-08-24 雀巢产品技术援助有限公司 用于减少婴儿代谢应激、降低肠道通透性和接近母乳喂养婴儿的生长速度的营养组合物

Also Published As

Publication number Publication date
CN104351796A (zh) 2015-02-18
EP2547216B1 (en) 2017-11-15
WO2011115490A1 (en) 2011-09-22
MY166016A (en) 2018-05-21
EP2547217B1 (en) 2017-07-19
RU2015130598A (ru) 2018-12-24
CN102905542A (zh) 2013-01-30
US20150306117A1 (en) 2015-10-29
WO2011115476A1 (en) 2011-09-22
WO2011115491A1 (en) 2011-09-22
ES2656154T3 (es) 2018-02-23
RU2559113C2 (ru) 2015-08-10
EP3332649B1 (en) 2024-04-24
RU2692920C2 (ru) 2019-06-28
CN102892300A (zh) 2013-01-23
ES2642635T3 (es) 2017-11-17
RU2560861C2 (ru) 2015-08-20
RU2012144021A (ru) 2014-04-27
PL2547217T3 (pl) 2018-01-31
BR112012023264A2 (pt) 2015-09-15
RU2015127482A3 (ru) 2018-12-24
BR112012023264A8 (pt) 2015-10-20
US20130096087A1 (en) 2013-04-18
EP2547216A1 (en) 2013-01-23
US20170151203A1 (en) 2017-06-01
EP3272221A1 (en) 2018-01-24
CN102892300B (zh) 2016-03-30
US10548869B2 (en) 2020-02-04
PL2547216T3 (pl) 2018-04-30
EP2547217A1 (en) 2013-01-23
RU2012144016A (ru) 2014-04-27
RU2015130598A3 (ru) 2018-12-24
US20130071446A1 (en) 2013-03-21
US9474764B2 (en) 2016-10-25
EP3332649A1 (en) 2018-06-13
BR112012023267A2 (pt) 2017-10-03
CN102905542B (zh) 2014-10-22
RU2692627C2 (ru) 2019-06-25

Similar Documents

Publication Publication Date Title
RU2015127482A (ru) Детское питание для улучшения состава жирных кислот в мембранах клеток мозга
Conquer et al. Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores
RU2014101160A (ru) Эффекты метаболического импринтинга специально разработанного липидного компонента
RU2015140733A (ru) Содержащие структурированные жировые глобулы питательные композиции и их применение
RU2011128449A (ru) Композиции для питания с покрытыми липидными глобулами
HRP20120929T1 (hr) Prehrambeni pripravci koji sadrže obložene lipidne globule
CN108651996A (zh) 一种健脑益智营养组合物及其应用
WO2010139702A2 (en) Nutritional composition for supporting brain development and function of children
RU2016121411A (ru) Липидная композиция для улучшения состава тела во время догоняющего роста
JP2008542280A5 (ru)
ES2937175T3 (es) Fórmulas para lactantes con arquitectura lipídica especial para promover el crecimiento saludable
ES2964285T3 (es) Fórmula para lactantes con grasa láctea para promover un crecimiento saludable
CN101554190B (zh) 含两种必需脂肪酸的食用油
RU2017138937A (ru) Пища с крупными липидными глобулами, включающими растительный жир, с покрытием из фосфолипидов молока для улучшения всасывания жира
RU2014113580A (ru) Применение детской молочной смеси с крупными липидными глобулами
CN111328882A (zh) 一种仿人乳脂肪球结构乳液及其制备方法
Jiang et al. Preparation of human milk fat substitutes: a review
Qiu et al. Biosafety evaluation of Nannochloropsis oculata and Schizochytrium sp. oils as novel human milk fat substitutes
Ma et al. Novel trends and challenges in fat modification of next-generation infant formula: Considering the structure of milk fat globules to improve lipid digestion and metabolism of infants
CN107072277A (zh) 用于改善行为的脂质组合物
Khor Implications of maternal diet on breast milk docosahexaenoic acid 22: 6n-3 (DHA) and arachidonic acid 20: 4n-6 (AA) contents: A narrative review
Wang et al. The rapid effects of eicosapentaenoic acid (EPA) enriched phospholipids on alleviating exercise fatigue in mice
ES2866349T3 (es) Composición nutricional para mejorar las membranas celulares
Borduas Lipid Crystallinity in O/W Emulsions Alters In vitro Lipid Digestion Kinetics
CN109805409A (zh) 一种提高记忆的保健食品